News

Sisters of Charity Hospital Zagreb: AI and Robots for Significant Progress

Sisters of Charity Hospital Zagreb: AI and Robots for Significant Progress
Pexels

March 25, 2023 - Significant progress is happening at the Sisters of Charity Hospital in Zagreb. Artificial intelligence, with the assistance of the Micromate robotic arm placed on the CT device, enables a probe for the thermal destruction of a tumor to be precisely positioned in the body after the initial imaging.

As 24Sata writes, at the Clinical Institute for Diagnostic and Interventional Radiology of the Sisters of Charity Hospital, for the first time in Croatia, percutaneous ablation procedures and tumor biopsies were successfully performed on oncology patients using the latest robotic arm technology, it was announced at the Sisters of Charity Hospital.

Artificial intelligence, with the assistance of the Micromate robotic arm placed on the CT device, enables the probe for the thermal destruction of the tumor to be precisely positioned in the body after the initial imaging.

This represents significant help for precise navigation even to the most difficult to reach or difficult to see small tumors with a significantly lower amount of radiation for the patient, says the press release signed by the Director of Sisters of Charity Hospital, prof. Ph.D. Davor Vagić, MD. and the Clinical Institute for Diagnostic and Interventional Radiology Sisters of Charity Hospital, Ph.D. Luka Novosel, subspecialist of interventional radiology.

All of the above, at the same time, speeds up the procedure itself. The aforementioned robotic arm system has been used by oncology departments around the world for three years and recently by larger oncology centers in Europe.

Recognized as a center of excellence in the minimally invasive treatment of oncology patients in this part of Europe, the Department of Interventional Radiology of Sisters of Charity Hospital was provided with this technology to test all the possibilities and advantages of this system, which is planned to be used in the future for the majority of oncology patients.

For more, make sure to check out our dedicated News section.

Search